4 trials changed in the last 30 days: 1 stopped, 1 with a notable change, 2 with minor changes only.
Recruitment suspended
Sponsor's reason: Planned interim analyse
Also in this update: Primary completion pushed from Jul 8, 2026 to Jan 2027; Study completion pushed from Oct 31, 2027 to Jan 2029
Institut Paoli-CalmettesPhase 2 NCT06055621 Registry history of NCT06055621 on ClinicalTrials.gov (opens the registry)
Updated
Primary and study completion pushed from Nov 1, 2027 to Nov 2029
Institut Paoli-CalmettesNot applicable NCT06046794 Registry history of NCT06046794 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Primary completion date changed from estimate of Jul 7, 2026 to May 27, 2026
Institut Paoli-CalmettesPhase 2 NCT01985061 Registry history of NCT01985061 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Oct 2021); last known: Not Yet Recruiting
Institut Paoli-CalmettesNot applicable NCT05054231 Registry history of NCT05054231 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-06 | NCT07861971 Feasibility Study of a Sports-Inspired Onco-Coaching Progranm for Young Adults i Cancer… | Recruiting | |
| 2026-10-05 | NCT07857486 Reduction of Neoadjuvant Treatment in Early Triple-Negative Breast Cancer | Phase 2 | Not Yet Recruiting |
| 2026-09-18 | NCT07827911 Predicting Pancreatic Fistula After Pancreatic Surgery Using Preoperative Immunity | Not Yet Recruiting |
| Phase 1 | 1 | |
| Phase 1/2 | 2 | |
| Phase 2 | 6 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06557421 | De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML… | Acute Myeloid Leukemia | Recruiting | 2026-03-13 |
| NCT07857486 | Reduction of Neoadjuvant Treatment in Early Triple-Negative Breast Cancer | Early Triple-Negative Breast Cancer | Not Yet Recruiting | 2026-10-05 |
| NCT03597321 | Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML | Acute Myeloid Leukemia | Active, Not Recruiting | 2026-09-29 |
| NCT07598110 | FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM… | Acute Myeloid Leukemia | Not Yet Recruiting | 2026-05-20 |
| NCT03515798 | Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory… | Inflammatory Breast Cancer | Active, Not Recruiting | 2025-09-12 |
| NCT04451200 | Sequential and Personalized PK-guided Busulfan Administration in the Frame of the… | Acute Leukemia | Not Yet Recruiting | 2020-11-17 |
| Phase 1/2 | ||||
| NCT05986071 | I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2… | Breast Cancer | Not Yet Recruiting | 2024-03-29 |
| NCT05519670 | A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With… | Breast Cancer | Not Yet Recruiting | 2022-08-29 |
| Phase 1 | ||||
| NCT05143970 | A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With… | Metastatic Cancer | Active, Not Recruiting | 2026-06-22 |
| Not applicable | ||||
| NCT06882486 | Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major… | Kidney Cancer | Recruiting | 2026-10-14 |
| NCT04185272 | Butyrophilins Role in Colon Cancer | Colonic Cancer | Recruiting | 2026-10-01 |
| NCT06046794 | Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic… | Cancer Of Pancreas | Recruiting | 2026-09-29 |
| NCT07608835 | IMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary… | Non-small Cell Lung Cancer | Recruiting | 2026-05-27 |
| NCT04520932 | Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic… | Neuroendocrine Tumor of Pancreas (Disorder) | Recruiting | 2025-05-25 |
| NCT03977779 | Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of… | Obstructive Jaundice | Recruiting | 2024-10-24 |
| NCT03185039 | Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer… | Kidney Cancer | Active, Not Recruiting | 2026-10-14 |
| NCT07592819 | A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for… | Pancreas Adenocarcinoma (MSI-H) | Not Yet Recruiting | 2026-05-18 |
| NCT01977274 | Predictive Clinical and Biological Parameters in Gynecological Cancer | Ovarian Cancer | Active, Not Recruiting | 2026-03-31 |
| NCT07461142 | Reduction of Hematologic Toxicity in Locally Advanced Cervical Cancers | Cervical Cancer by FIGO Stage 2018 | Not Yet Recruiting | 2026-03-10 |
| NCT05529862 | Trans-RosaLEE Study: a Biomarker-directed, Translational Study | Advanced or Metastatic Breast Cancer (BC) | Active, Not Recruiting | 2026-01-22 |
| NCT03595787 | COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia… | Acute Myeloid Leukemia | Active, Not Recruiting | 2024-12-18 |
| NCT01717131 | Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel… | Invasive Breast Cancer | Active, Not Recruiting | 2024-01-11 |
| NCT06000553 | Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal… | PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS | Not Yet Recruiting | 2023-08-21 |
| NCT05802485 | PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT | Pancreatic Cancer Non-resectable | Not Yet Recruiting | 2023-04-06 |
| NCT05602168 | Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the… | Hematologic Cancer | Not Yet Recruiting | 2022-11-01 |
Breast Cancer (10) · Pancreatic Cancer (8) · Leukemia (7) · Ovarian Cancer (5) · Acute Myeloid Leukemia (AML) (4) · Colorectal Cancer (4) · Cervical Cancer (3) · Endometrial Cancer (2) · Gastric Cancer (2) · Kidney Cancer (2)